Ergoteles’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-60,549
| Closed | -$760K | – | 342 |
|
|
2023
Q2 | $760K | Sell |
60,549
-261,595
| -81% | -$3.29M | 0.04% | 535 |
|
|
2023
Q1 | $3.57M | Buy |
322,144
+112,678
| +54% | +$1.25M | 0.14% | 123 |
|
|
2022
Q4 | $2.56M | Buy |
209,466
+183,197
| +697% | +$2.24M | 0.09% | 220 |
|
|
2022
Q3 | $274K | Buy |
+26,269
| New | +$274K | 0.01% | 1023 |
|
|
2021
Q3 | – | Sell |
-17,638
| Closed | -$170K | – | 1366 |
|
|
2021
Q2 | $170K | Buy |
+17,638
| New | +$170K | ﹤0.01% | 1326 |
|
|
2020
Q4 | – | Sell |
-18,100
| Closed | -$256K | – | 755 |
|
|
2020
Q3 | $256K | Buy |
+18,100
| New | +$256K | 0.03% | 392 |
|